HSA Approval

NEUROFIND PROLONGED RELEASE TABLETS 18 MG

Approval Number

SIN17020P

Drug Name

Product Name

NEUROFIND PROLONGED RELEASE TABLETS 18 MG

Approval Date

June 5, 2024

Registrant

LOTUS INTERNATIONAL PTE. LTD.

Regulatory Information

Registrant

LOTUS INTERNATIONAL PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route of Administration

ORAL

Medical Information

ATC Code

N06BA04

Manufacturer Information

Pharmaceutical Manufacturer

LOTUS INTERNATIONAL PTE. LTD.

Manufacturers

Laboratorios LICONSA S.A.

Active Ingredients

Ingredient Name

Methylphenidate Hydrochloride

Strength

18 mg

Drug MonographMethylphenidate

Documents

Package Inserts

Neurofind Prolonged Release Tablets PI.pdf

Approved: June 5, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

NEUROFIND PROLONGED RELEASE TABLETS 18 MG - HSA Approval | MedPath

AI-Powered Research

Premium Access

NEUROFIND PROLONGED RELEASE TABLETS 18 MG

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

Documents

Package Inserts

MedPath

Product

Company

Legal